No significant difference in accuracy seen between SPAT using ≥4.5-mm cutoff and SPT for birch, house dust mite allergy
TUESDAY, July 15, 2025 (HealthDay News) — Compared with the conventional skin prick test (SPT), the novel Skin Prick Automated Test (SPAT) shows equivalent accuracy to detect birch pollen or house-dust mite allergy using a cutoff of 4.5 mm, according to a study published online July 9 in Allergy.
Noting that SPAT previously showed reduced variability and more consistent results versus the conventional SPT for identifying allergic sensitization, Sven F. Seys, Ph.D., from Hippo Dx in Aarschot, Belgium, and colleagues validated the SPAT cut-off in patients with confirmed birch or house-dust mite allergy. Seventy-five adults were included in the study: 25 who were nonallergic, 25 with birch allergic rhinitis, and 25 with house-dust mite allergic rhinitis, confirmed by positive SPT and a nasal allergen challenge.
The researchers found that the highest accuracy for detecting birch and house-dust mite allergy using SPAT was with a cut-off of 4.2 and 4.1 mm, respectively. Noting that previous results suggested a reliable cutoff of 4.5 mm, it was decided to maintain 4.5 mm as the SPAT cut-off indicating allergic sensitization. No significant difference was seen in accuracy between SPAT (96 percent using ≥4.5 mm) and conventional SPT (98 percent using ≥3.0 mm) to detect house-dust mite allergy or birch pollen allergy (100 percent for both). No significant difference was seen for any of the patient groups using SPAT wheal measurements performed through a ruler on the forearm or through digital measurement on a composite image.
“Validation of the SPAT outcomes in allergic rhinitis patients with clinically relevant respiratory allergy now allows widespread use of the device both in research and clinical practice,” the authors write.
Several authors disclosed ties to Hippocreates. The study was funded by Hippo Dx.
Abstract/Full Text (subscription or payment may be required)
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis
U.S. Adults May Not Understand Their Risk for Vascular Disease
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk
Polypharmacy of Prescription Medications Increased for U.S. Older Adults
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline